Bridgebio Pharma Inc (BBIO)

EBITDA Margin

-85.72%

TTM · Period ending:

BBIO logo

BBIO EBITDA Margin

Latest reported-85.72%
BBIO EBITDA Margin (0.00% → -85.72%)
High-resolution chart · PNG

BBIO ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-134.7299%
-196.8567%
-6,078.3403%
-511.8522%
-765.7252%
-5,665.8625%
-687.7737%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.